Wells Fargo’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-322
| Closed | -$6.32K | – | 7139 |
|
2023
Q3 | $6.32K | Buy |
+322
| New | +$6.32K | ﹤0.01% | 5546 |
|
2022
Q2 | – | Sell |
-225
| Closed | -$6K | – | 6488 |
|
2022
Q1 | $6K | Hold |
225
| – | – | ﹤0.01% | 6058 |
|
2021
Q4 | $9K | Hold |
225
| – | – | ﹤0.01% | 6030 |
|
2021
Q3 | $10K | Hold |
225
| – | – | ﹤0.01% | 5865 |
|
2021
Q2 | $11K | Sell |
225
-154
| -41% | -$7.53K | ﹤0.01% | 5772 |
|
2021
Q1 | $19K | Sell |
379
-691
| -65% | -$34.6K | ﹤0.01% | 5804 |
|
2020
Q4 | $53K | Hold |
1,070
| – | – | ﹤0.01% | 5371 |
|
2020
Q3 | $42K | Buy |
1,070
+845
| +376% | +$33.2K | ﹤0.01% | 5315 |
|
2020
Q2 | $10K | Hold |
225
| – | – | ﹤0.01% | 5502 |
|
2020
Q1 | $7K | Hold |
225
| – | – | ﹤0.01% | 5503 |
|
2019
Q4 | $9K | Hold |
225
| – | – | ﹤0.01% | 5580 |
|
2019
Q3 | $5K | Sell |
225
-729
| -76% | -$16.2K | ﹤0.01% | 5632 |
|
2019
Q2 | $27K | Sell |
954
-25
| -3% | -$708 | ﹤0.01% | 5385 |
|
2019
Q1 | $27K | Buy |
979
+25
| +3% | +$689 | ﹤0.01% | 5349 |
|
2018
Q4 | $22K | Buy |
954
+225
| +31% | +$5.19K | ﹤0.01% | 5415 |
|
2018
Q3 | $25K | Hold |
729
| – | – | ﹤0.01% | 5440 |
|
2018
Q2 | $24K | Hold |
729
| – | – | ﹤0.01% | 5468 |
|
2018
Q1 | $24K | Hold |
729
| – | – | ﹤0.01% | 5432 |
|
2017
Q4 | $21K | Hold |
729
| – | – | ﹤0.01% | 5433 |
|
2017
Q3 | $21K | Hold |
729
| – | – | ﹤0.01% | 5374 |
|
2017
Q2 | $18K | Hold |
729
| – | – | ﹤0.01% | 5324 |
|
2017
Q1 | $17K | Hold |
729
| – | – | ﹤0.01% | 5377 |
|
2016
Q4 | $13K | Buy |
+729
| New | +$13K | ﹤0.01% | 5394 |
|